We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.46B
1-Year Est. Return 26.64%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
+26.64%
3 Year Est. Return
+96.4%
5 Year Est. Return
+160.76%
10 Year Est. Return
–
AUM
$5.19B
AUM Growth
+$431M
Cap. Flow
+$353M
Cap. Flow %
6.8%
Top 10 Hldgs %
35.34%
Holding
153
New
23
Increased
48
Reduced
47
Closed
27

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$130M
2
HTO
H2O America
HTO
+$102M
3
DIS icon
Walt Disney
DIS
+$69.5M
4
WDAY icon
Workday
WDAY
+$69M
5
PGR icon
Progressive
PGR
+$60.7M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$62.8M
2
META icon
Meta Platforms (Facebook)
META
+$53.2M
3
LEN icon
Lennar Class A
LEN
+$34.4M
4
WLK icon
Westlake Corp
WLK
+$30.8M
5
EGO icon
Eldorado Gold
EGO
+$25M

Sector Composition

Rank Sector Weight
1 Utilities 28.74%
2 Technology 13.47%
3 Healthcare 12.72%
4 Energy 9.26%
5 Consumer Discretionary 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
101
Boston Scientific
BSX
$71.4B
$70.8K ﹤0.01%
+1,128
New +$90.2K
SIBN icon
102
SI-BONE Inc
SIBN
$813M
$70.3K ﹤0.01%
5,564
+4,094
+279% +$64.1K
TEVA icon
103
Teva Pharmaceuticals
TEVA
$40.6B
$67.3K ﹤0.01%
2,234
+148
+7% +$4.76K
ORA icon
104
Ormat Technologies
ORA
$6.6B
$60.4K ﹤0.01%
+540
New +$62.7K
VRTX icon
105
Vertex Pharmaceuticals
VRTX
$123B
$56.7K ﹤0.01%
127
– –
NTRA icon
106
Natera
NTRA
$38B
$56K ﹤0.01%
280
-50
-15% -$10.8K
KWEB icon
107
CALL
KraneShares CSI China Internet ETF
KWEB
$5.62B
$48.5K ﹤0.01%
+2,206
New +$72.3K
GE icon
108
GE Aerospace
GE
$389B
$40K ﹤0.01%
141
– –
TARS icon
109
Tarsus Pharmaceuticals
TARS
$2.85B
$38.9K ﹤0.01%
+555
New +$38.8K
ARGX icon
110
argenx
ARGX
$54.8B
$36.5K ﹤0.01%
50
-146
-74% -$114K
DXCM icon
111
DexCom
DXCM
$31.3B
$34.8K ﹤0.01%
554
-304
-35% -$21.2K
TNGX icon
112
Tango Therapeutics
TNGX
$4.72B
$33.9K ﹤0.01%
1,622
-2,891
-64% -$40.2K
IDYA icon
113
IDEAYA Biosciences
IDYA
$3.49B
$30.6K ﹤0.01%
917
-233
-20% -$7.82K
DNTH icon
114
Dianthus Therapeutics
DNTH
$6.15B
$30.5K ﹤0.01%
364
-95
-21% -$5.5K
IRON icon
115
Disc Medicine
IRON
$2.97B
$30.4K ﹤0.01%
476
+57
+14% +$3.96K
NUVL
116
DELISTED
Nuvalent
NUVL
$28.2K ﹤0.01%
275
-116
-30% -$11.8K
MASS icon
117
908 Devices
MASS
$341M
$26.9K ﹤0.01%
4,402
-692
-14% -$4.33K
ATAI icon
118
AtaiBeckley Inc
ATAI
$2.66B
$26.7K ﹤0.01%
7,529
+448
+6% +$1.69K
TERN
119
DELISTED
Terns Pharmaceuticals
TERN
$24K ﹤0.01%
+455
New +$18.7K
RLMD icon
120
Relmada Therapeutics
RLMD
$564M
$21.1K ﹤0.01%
+3,035
New +$14.4K
VRDN icon
121
Viridian Therapeutics
VRDN
$2.49B
$16.3K ﹤0.01%
834
-316
-27% -$9.38K
ORIC icon
122
Oric Pharmaceuticals
ORIC
$1.34B
$16.2K ﹤0.01%
1,278
-1,121
-47% -$12.7K
BIOA
123
BioAge Labs
BIOA
$501M
$16K ﹤0.01%
+915
New +$17.6K
CABA icon
124
Cabaletta Bio
CABA
$450M
$15.1K ﹤0.01%
5,616
-11,571
-67% -$32.1K
SQM icon
125
Sociedad Química y Minera de Chile
SQM
$20.7B
$14.7K ﹤0.01%
182
– –
3 4
5
6 7

Similar funds

DWA
Douglass Winthrop Advisors New York $5.46B AUM 11.49% 1-Year Est. Return
GVAG
Great Valley Advisor Group Wilmington, Delaware $5.5B AUM 20.56% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
LP
Linonia Partnership New York $5.38B AUM 20.54% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return

Antipodes Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Antipodes Partners held 153 positions worth $5.19B, up 9.1% from $4.76B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Antipodes Partners deployed $353M of net new capital in Q1 2026, opening 23 new positions and adding to 48 existing holdings. Its largest new stake was NVIDIA: 710,665 shares worth $124M.

By sector, the portfolio is most concentrated in Utilities at 29% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $53.2M trimmed.

  • Antipodes Partners's largest Q1 2026 buy was NVIDIA: 710,665 shares worth $124M.
  • Antipodes Partners added most to H2O America in Q1 2026, an estimated $102M increase.
  • Antipodes Partners's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $53.2M.
  • Antipodes Partners fully exited Advanced Micro Devices in Q1 2026, selling an estimated $62.8M.
  • Antipodes Partners's ten largest holdings make up 35% of its $5.19B portfolio in Q1 2026.
  • Antipodes Partners opened 23 new positions and closed 27 in Q1 2026.
  • Antipodes Partners's portfolio value rose 9.1% quarter-over-quarter to $5.19B.

Based on Antipodes Partners's 13F filing for Q1 2026, filed 5 May 2026.